Renaissance Technologies Portfolio holdings
Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$839M |
| 2 |
Amazon
AMZN
|
+$810M |
| 3 |
Tesla
TSLA
|
+$644M |
| 4 |
TSMC
TSM
|
+$546M |
| 5 |
Johnson & Johnson
JNJ
|
+$389M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$891M |
| 2 |
Home Depot
HD
|
+$441M |
| 3 |
JPMorgan Chase
JPM
|
+$335M |
| 4 |
NVO
Novo Nordisk
NVO
|
+$317M |
| 5 |
ASML
ASML
|
+$315M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 20.81% |
| 2 | Technology | 15.51% |
| 3 | Consumer Discretionary | 11.84% |
| 4 | Consumer Staples | 10.09% |
| 5 | Financials | 9.61% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3201
CorMedix
CRMD
$582M
| $311K | ﹤0.01% |
73,600
+60,000
| +441% | +$212K |
|
3202
PEDEVCO
PED
$136M
| $311K | ﹤0.01% |
14,145
-13,815
| -49% | -$321K |
|
3203
Stock Yards Bancorp
SYBT
$2.65B
| $311K | ﹤0.01% |
4,790
+100
| +2% | +$7.15K |
|
3204
Krispy Kreme
DNUT
$540M
| $309K | ﹤0.01% |
+29,900
| New | +$407K |
|
3205
KFA Mount Lucas Managed Futures Index Strategy ETF
KMLM
$408M
| $309K | ﹤0.01% |
+10,100
| New | +$362K |
|
3206
Direxion Daily Retail Bull 3X ETF
RETL
$29.1M
| $309K | ﹤0.01% |
44,400
-21,226
| -32% | -$165K |
|
3207
Protalix BioTherapeutics
PLX
$197M
| $308K | ﹤0.01% |
224,603
+107,403
| +92% | +$118K |
|
|
JNCE
3208
DELISTED
Jounce Therapeutics, Inc. Common Stock
JNCE
| $307K | ﹤0.01% |
276,896
+197,196
| +247% | +$281K |
|
3209
Donaldson
DCI
$11.3B
| $306K | ﹤0.01% |
5,200
-50,500
| -91% | -$2.89M |
|
3210
Vor Biopharma
VOR
$1.24B
| $306K | ﹤0.01% |
2,298
+703
| +44% | +$69.6K |
|
|
TBHC
3211
DELISTED
The Brand House Collective
TBHC
| $304K | ﹤0.01% |
92,100
-31,300
| -25% | -$115K |
|
3212
PrimeEnergy Resources
PNRG
$302M
| $304K | ﹤0.01% |
3,500
+200
| +6% | +$16.1K |
|
3213
ARK Innovation ETF
ARKK
$6.01B
| $303K | ﹤0.01% |
+9,700
| New | +$347K |
|
3214
State Street SPDR Bloomberg International Treasury Bond ETF
BWX
$1.31B
| $303K | ﹤0.01% |
+13,500
| New | +$293K |
|
3215
Better Online Solutions
BOSC
$31.7M
| $302K | ﹤0.01% |
144,511
-15,584
| -10% | -$34.6K |
|
3216
Cooper-Standard Automotive
CPS
$508M
| $301K | ﹤0.01% |
33,200
+8,900
| +37% | +$63K |
|
|
RENT
3217
Rent the Runway
RENT
$120M
| $301K | ﹤0.01% |
4,940
+3,700
| +298% | +$150K |
|
3218
Bristow Group
VTOL
$1.37B
| $301K | ﹤0.01% |
11,100
-1,000
| -8% | -$26.1K |
|
3219
Abercrombie & Fitch
ANF
$4.9B
| $300K | ﹤0.01% |
13,100
-42,300
| -76% | -$833K |
|
3220
Bakkt Inc
BKKT
$322M
| $300K | ﹤0.01% |
10,068
+312
| +3% | +$14.6K |
|
3221
Corporacion America
CAAP
$4.34B
| $299K | ﹤0.01% |
+34,200
| New | +$277K |
|
3222
HBT Financial
HBT
$1.31B
| $299K | ﹤0.01% |
15,300
-2,800
| -15% | -$55.1K |
|
3223
iShares Russell Mid-Cap ETF
IWR
$56.8B
| $297K | ﹤0.01% |
4,400
-2,300
| -34% | -$155K |
|
3224
Palladyne AI
PDYN
$280M
| $297K | ﹤0.01% |
+88,069
| New | +$751K |
|
3225
FRP Holdings
FRPH
$419M
| $296K | ﹤0.01% |
11,000
+200
| +2% | +$5.71K |
|
Similar funds
Renaissance Technologies's Q4 2022 Portfolio in Review
As of Q4 2022, Renaissance Technologies held 4,601 positions worth $73.1B, up 3.4% from $70.7B the previous quarter. Its ten largest holdings account for 11% of the portfolio.
Renaissance Technologies's Q4 2022 filing shows 626 new, 1,390 increased, 2,018 reduced and 524 closed positions. Its largest new stake was Johnson & Johnson: 2,254,125 shares worth $398M. The largest sale was Microsoft, an estimated $891M.
By sector, the portfolio is most concentrated in Healthcare at 21% of assets, up from 19% a quarter earlier, followed by Technology and Consumer Discretionary.
- Renaissance Technologies's largest Q4 2022 buy was Johnson & Johnson: 2,254,125 shares worth $398M.
- Renaissance Technologies added most to Apple in Q4 2022, an estimated $839M increase.
- Renaissance Technologies's biggest Q4 2022 reduction was Novo Nordisk, cutting an estimated $317M.
- Renaissance Technologies fully exited Microsoft in Q4 2022, selling an estimated $891M.
- Renaissance Technologies's ten largest holdings make up 11% of its $73.1B portfolio in Q4 2022.
- Renaissance Technologies opened 626 new positions and closed 524 in Q4 2022.
- Renaissance Technologies's portfolio value rose 3.4% quarter-over-quarter to $73.1B.
Based on Renaissance Technologies's 13F filing for Q4 2022, filed 13 Feb 2023.